Preview

Fine Chemical Technologies

Advanced search

Synthesis and biological activity of arylheteraaliphatic amino amides

Full Text:

Abstract

The synthesis of a series of N-substituted arylheteraaliphatic amino amides was carried out to determine their antiarrhythmic activity. Styrene oxide was the initial compound for the synthesis. Its oxirane ring was opened with N,N-dialkylaminoethanols in the presence of alcoholates. It was found that the opening of the oxirane ring was carried out mainly according to the Krasusky rule on the bond between the oxygen atom and the less substituted carbon atom. A mixture of two products with the predominance of the secondary amino alcohol was created. The main product was separated by multiple vacuum distillations. 2-[2-(Dialkylamino) ethoxy]-1-phenylethanols were obtained and used in the Ritter reaction for the alkylation of benzonitrile in the presence of sulfuric acid to give N-{2-[2-(dialkylamino)ethoxy]-1-phenylethyl} benzamides. Biological tests of the obtained compounds were carried on the aconitine arrhythmia model out in rats. Procainamide, Quinidine, Lidocaine and Ethacyzin were used as the drugs. The findings in this study indicate that most of the obtained compounds have a low toxicity and expressed antiarrhythmic activity.

About the Authors

А. I. Ivanova
M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571
Russian Federation


Е. Ya. Borisova
M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571
Russian Federation


N. Yu. Borisova
M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571
Russian Federation


D. Q. Hoang
M.V. Lomonosov Moscow State University of Fine Chemical Technologies, 86, Vernadskogo pr., Moscow 119571
Russian Federation


Е. V. Arzamastsev
Russian Cardiology Research and Production Complex, Moscow, 121552
Russian Federation


References

1. Машковский М.Д. Лекарственные средства. В 2-х т. М.: Новая волна, 2002. Т. 1. 608 с. Т.

2. 539 с. 2. Gadhachanda V.R., Wu B., Wang Z., Kuhen K.L., Caldwell J., Zondler H., Walter H., Havenhand M., He Y. // Bioorgan. & Med. Chem. Lett. 2007. V.17(1). P. 260-265.

3. Ghidini E., Delcanale M., Fanti R., Rizzi A., Mazzuferi M., Rodi D. // Bioorgan. & Med. Chem. 2006. V. 14. P. 3263-3274.

4. Zhang H. Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors: pat. US 2010/0240649 A1; filed 26.05.2010; pub. 23.09.2010.

5. Иванова А.И., Борисова Н.Ю., Борисова Е.Я., Федорова Г.А., Васильева Г.А., Афанасьева Е.Ю., Арзамасцев Е.В., Самарова О.С. // Известия АН. Сер. хим. 2015. № 1. С. 92-98.

6. Мохаммед А.Х., Борисова Н.Ю., Борисова Е.Я. // Вестник МИТХТ. 2011. Т. 6. № 6. С. 69-71.

7. Беленький М.Л. Элементы количественной оценки фармакологического эффекта. Л.: Медгиз, 1963. 262 с.

8. Szekeres L. // Progress in Pharmacology. 1979. V. 2/4. P. 25-31.


For citation:


Ivanova А.I., Borisova Е.Y., Borisova N.Yu., Hoang D.Q., Arzamastsev Е.V. Synthesis and biological activity of arylheteraaliphatic amino amides. Fine Chemical Technologies. 2015;10(1):45-49. (In Russ.)

Views: 95


ISSN 2410-6593 (Print)
ISSN 2686-7575 (Online)